Safety and efficacy study of ‘Shreshthadi vati’ in management of ‘Madhumeha’ with special reference to type-2 diabetes mellitus.

Not Applicable

Completed

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2022/11/047514
• Lead Sponsor: ational Institute Of Ayurveda Deemed To Be University Jaipur Rajasthan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-05-31
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 33

Inclusion Criteria

1. Patient ready to give consent for trial and willing to participate in the study.

2. Patient between the age group of 18-70 years.

3. Sex- male and female patient.

4. Newly diagnosed (not more than 2 years) case of Madhumeha (Type 2 diabetes mellitus).

5. Patient with FBS –in range of 126-200mg/dl

PPBS-in range of 200-300mg/dl

Exclusion Criteria

1. Patient not willing to sign the consent form.

2. Patients having Type-1 Diabetes Mellitus.

3. FBS >200 mg/dl and PPBS >300 mg/dl.

4. Patients of Type-2 diabetes mellitus who are on insulin therapy and Drug induced diabetes mellitus.

5. Type-2 diabetes mellitus with complications and Madhumeha with Ashadhya upadrava.

6. Patients having any serious illness like cardiovascular diseases, renal disease, hepatic disease, malignancy, any other endocrinopathies etc.

7. Pregnant and lactating mother.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
changes in objectives parameter- F.B.S. ,P.P.B.S.from baseline value.Timepoint: 30 days

Secondary Outcome Measures

Name	Time	Method
Changes in the clinical symptoms of Mahdumeha (Type 2 diabetes <br/ ><br>mellitus)Timepoint: 30 days